262 related articles for article (PubMed ID: 37535247)
1. Synergistic neuroprotection by phytocompounds of Bacopa monnieri in scopolamine-induced Alzheimer's disease mice model.
Shoukat S; Zia MA; Uzair M; Alsubki RA; Sajid K; Shoukat S; Attia KA; Fiaz S; Ali S; Kimiko I; Ali GM
Mol Biol Rep; 2023 Oct; 50(10):7967-7979. PubMed ID: 37535247
[TBL] [Abstract][Full Text] [Related]
2. The modulatory role of prime identified compounds in Geophila repens in mitigating scopolamine-induced neurotoxicity in experimental rats of Alzheimer's disease via attenuation of cholinesterase, β-secretase, MAPt levels and inhibition of oxidative stress imparts inflammation.
Dash UC; Swain SK; Kanhar S; Banjare P; Roy PP; Dandapat J; Sahoo AK
J Ethnopharmacol; 2022 Jan; 282():114637. PubMed ID: 34534598
[TBL] [Abstract][Full Text] [Related]
3. Quercetin stimulates the non-amyloidogenic pathway via activation of ADAM10 and ADAM17 gene expression in aluminum chloride-induced Alzheimer's disease rat model.
Elfiky AM; Mahmoud AA; Elreedy HA; Ibrahim KS; Ghazy MA
Life Sci; 2021 Nov; 285():119964. PubMed ID: 34537230
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effect of Saroglitazar on Scopolamine-Induced Alzheimer's in Rats: Insights into the Underlying Mechanisms.
Sandeep Ganesh G; Konduri P; Kolusu AS; Namburi SV; Chunduru BTC; Nemmani KVS; Samudrala PK
ACS Chem Neurosci; 2023 Sep; 14(18):3444-3459. PubMed ID: 37669120
[TBL] [Abstract][Full Text] [Related]
5. Revalidation of the neuroprotective effects of a United States patented polyherbal formulation on scopolamine induced learning and memory impairment in rats.
Upadhyay P; Sadhu A; Singh PK; Agrawal A; Ilango K; Purohit S; Dubey GP
Biomed Pharmacother; 2018 Jan; 97():1046-1052. PubMed ID: 29136783
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of neuroprotective effect of quercetin with donepezil in scopolamine-induced amnesia in rats.
Pattanashetti LA; Taranalli AD; Parvatrao V; Malabade RH; Kumar D
Indian J Pharmacol; 2017; 49(1):60-64. PubMed ID: 28458424
[TBL] [Abstract][Full Text] [Related]
7. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease model.
Uabundit N; Wattanathorn J; Mucimapura S; Ingkaninan K
J Ethnopharmacol; 2010 Jan; 127(1):26-31. PubMed ID: 19808086
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats.
Abhishek M; Rubal S; Rohit K; Rupa J; Phulen S; Gurjeet K; Raj SA; Manisha P; Alka B; Ramprasad P; Bikash M
J Ethnopharmacol; 2022 Jul; 293():115199. PubMed ID: 35346813
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective mechanisms of defatted walnut powder against scopolamine-induced Alzheimer's disease in mice revealed through metabolomics and proteomics analyses.
Xu X; Ding Y; Liu M; Zhang X; Wang D; Pan Y; Ren S; Liu X
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117107. PubMed ID: 37652196
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
[TBL] [Abstract][Full Text] [Related]
11. Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease.
Dubey T; Chinnathambi S
Arch Biochem Biophys; 2019 Nov; 676():108153. PubMed ID: 31622587
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological mechanism of xanthoangelol underlying Nrf-2/TRPV1 and anti-apoptotic pathway against scopolamine-induced amnesia in mice.
Syed Z; Shal B; Azhar A; Amanat S; Khan A; Ali H; Kil YS; Seo EK; Khan S
Biomed Pharmacother; 2022 Jun; 150():113073. PubMed ID: 35658216
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection with Bacopa monnieri-A review of experimental evidence.
Shalini VT; Neelakanta SJ; Sriranjini JS
Mol Biol Rep; 2021 Mar; 48(3):2653-2668. PubMed ID: 33675463
[TBL] [Abstract][Full Text] [Related]
14. A Diet Containing Rutin Ameliorates Brain Intracellular Redox Homeostasis in a Mouse Model of Alzheimer's Disease.
Bermejo-Bescós P; Jiménez-Aliaga KL; Benedí J; Martín-Aragón S
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902309
[TBL] [Abstract][Full Text] [Related]
15. Activation of Nrf2 signaling by sitagliptin and quercetin combination against β-amyloid induced Alzheimer's disease in rats.
Li Y; Tian Q; Li Z; Dang M; Lin Y; Hou X
Drug Dev Res; 2019 Sep; 80(6):837-845. PubMed ID: 31301179
[TBL] [Abstract][Full Text] [Related]
16. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
Sabogal-Guáqueta AM; Muñoz-Manco JI; Ramírez-Pineda JR; Lamprea-Rodriguez M; Osorio E; Cardona-Gómez GP
Neuropharmacology; 2015 Jun; 93():134-45. PubMed ID: 25666032
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of Bacopa monnieri on ischemia-induced cognitive deficits in mice: the possible contribution of bacopaside I and underlying mechanism.
Le XT; Nguyet Pham HT; Van Nguyen T; Minh Nguyen K; Tanaka K; Fujiwara H; Matsumoto K
J Ethnopharmacol; 2015 Apr; 164():37-45. PubMed ID: 25660331
[TBL] [Abstract][Full Text] [Related]
18. Investigating neuroprotective roles of Bacopa monnieri extracts: Mechanistic insights and therapeutic implications.
Fatima U; Roy S; Ahmad S; Al-Keridis LA; Alshammari N; Adnan M; Islam A; Hassan MI
Biomed Pharmacother; 2022 Sep; 153():113469. PubMed ID: 36076495
[TBL] [Abstract][Full Text] [Related]
19. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
Cai Z; Wang C; He W; Chen Y
Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective Role of Novel Triazine Derivatives by Activating Wnt/β Catenin Signaling Pathway in Rodent Models of Alzheimer's Disease.
Sinha A; Tamboli RS; Seth B; Kanhed AM; Tiwari SK; Agarwal S; Nair S; Giridhar R; Chaturvedi RK; Yadav MR
Mol Neurobiol; 2015 Aug; 52(1):638-52. PubMed ID: 25257697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
